...
首页> 外文期刊>Archives of pediatrics & adolescent medicine >Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.
【24h】

Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.

机译:早期在腹泻和体积膨胀相对nephroprotection在随后溶血性尿毒症综合征。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: To determine if interventions during the pre-hemolytic uremic syndrome (HUS) diarrhea phase are associated with maintenance of urine output during HUS. DESIGN: Prospective observational cohort study. SETTINGS: Eleven pediatric hospitals in the United States and Scotland. PARTICIPANTS: Children younger than 18 years with diarrhea-associated HUS (hematocrit level upper limit of reference range for age). INTERVENTIONS: Intravenous fluid was given within the first 4 days of the onset of diarrhea. OUTCOME MEASURE: Presence or absence of oligoanuria (urine output 1 day). RESULTS: The overall oligoanuric rate of the 50 participants was 68%, but was 84% among those who received no intravenous fluids in the first 4 days of illness. The relative risk of oligoanuria when fluids were not given in this interval was 1.6 (95% confidence interval, 1.1-2.4; P = .02). Children with oligoanuric HUS were given less total intravenous fluid (r = -0.32; P = .02) and sodium (r = -0.27; P = .05) in the first 4 days of illness than those without oligoanuria. In multivariable analysis, the most significant covariate was volume infused, but volume and sodium strongly covaried. CONCLUSIONS: Intravenous volume expansion is an underused intervention that could decrease the frequency of oligoanuric renal failure in patients at risk of HUS.
机译:目的:确定干预期间pre-hemolytic尿毒症综合症(HUS)腹泻阶段与维修相关的尿输出在溶血性尿毒综合征。观察性队列研究。在美国儿科医院苏格兰。年diarrhea-associated溶血性尿毒综合征(红细胞比容参考范围年龄的上限)。干预措施:静脉注射液体内的前4天出现腹泻。结果测量:存在与否oligoanuria(尿量 1天)。50个参与者是68%,而是84%那些没有接受静脉输液前4天的疾病。oligoanuria当液体没有给出间隔为1.6(95%置信区间,1.1 - -2.4;有少总静脉注射液体(r =-0.32;前4天的病比那些没有oligoanuria。重要的协变量是体积注入,但是体积和钠强烈共变。静脉注射体积膨胀是一个未得到充分利用干预,可以减少的频率oligoanuric肾功能衰竭患者的风险

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号